Research Solutions (NASDAQ:RSSS) Trading Up 6% – Should You Buy?

Research Solutions Inc. (NASDAQ:RSSS) shares were up 6% during mid-day trading on Wednesday . The company traded as high as $3.09 and last traded at $3.01. Approximately 158,175 shares traded hands during mid-day trading, an increase of 98% from the average daily volume of 80,036 shares. The stock had previously closed at $2.84.

Research Solutions Trading Up 6.0%

The stock has a fifty day moving average price of $2.80 and a 200-day moving average price of $2.88. The firm has a market capitalization of $97.70 million, a price-to-earnings ratio of -21.50, a PEG ratio of 3.16 and a beta of 0.67.

Institutional Investors Weigh In On Research Solutions

Hedge funds and other institutional investors have recently bought and sold shares of the business. Evernest Financial Advisors LLC acquired a new stake in Research Solutions during the 2nd quarter valued at $35,000. Cubist Systematic Strategies LLC acquired a new stake in Research Solutions during the 4th quarter valued at $56,000. Schonfeld Strategic Advisors LLC acquired a new stake in Research Solutions during the 4th quarter valued at $62,000. Millennium Management LLC acquired a new stake in Research Solutions during the 4th quarter valued at $65,000. Finally, Occudo Quantitative Strategies LP acquired a new stake in Research Solutions during the 4th quarter valued at $97,000. 33.60% of the stock is owned by institutional investors and hedge funds.

About Research Solutions

Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets.